News - North America


Current filters:

North America

Popular Filters

1883 to 1898 of 1898 results

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA


Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Merck KGaA US units agree $44.3 million settlement with DoJ; Ranbaxy faces up to $1 billion fine?


Four US subsidiaries of German drug major Merck KGaA (MRK: DE) - Serono Laboratories, EMD Serono, Merck…

LegalMerck KGaAMerck SeronoNorth AmericaPharmaceuticalRanbaxy LaboratoriesRebif

USA’s FDA and FTC act to remove fraudulent STD products from the market


The US Food and Drug Administration has joined forces with the Federal Trade Commission in a joint effort…

North AmericaPharmaceuticalRegulationReproductive

US shortages of key drugs are endangering patients


In the USA, doctors, hospitals and federal regulators are struggling to cope with an unprecedented surge…

Markets & MarketingNorth AmericaPharmaceutical

US FDA clears Boehringer and Lilly’s diabetes drug Tradjenta


The US Food and Drug Administration has approved Tradjenta (linagliptin), for use along with diet and…

Boehringer IngelheimDiabetesEli LillylinagliptinNorth AmericaPharmaceuticalRegulationTradjenta

Johnson & Johnson unit voluntarily withdraws NDA for trabectedin


Centocor Ortho Biotech Products, a division of US health care giant Johnson & Johnson (NYSE: JNJ), says…

Centocor Ortho BiotechJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRegulationtrabectedinYondelisZeltia

Takeda’s Millennium files two sNDAs for Velcade with US FDA


Japan’s largest drugmaker, Takeda Pharmaceutical (TSE: 4502), together with its US oncology subsidiary…

BiotechnologyMillennium PharmaceuticalsNorth AmericaOncologyPharmaceuticalRegulationTakeda PharmaceuticalsVelcade

US FDA not ready to approve Eisai Aricept Patch; Lipacreon and Halaven OKed in Japan


Japanese drug major Eisai (TYO: 4523) says that the US Food and Drug Administration has issued a Complete…

AriceptAsia-PacificEisaiHalavenLipacreonNeurologicalNorth AmericaOncologyPfizerPharmaceuticalRegulation

AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent


Anglo-Swedish drug major AstraZeneca (LSE: AZN and USA-based Pozen (Nasdaq; POZN) have filed a law suit…

Anti-Arthritics/RheumaticsAstraZenecaDr Reddy's LaboratoriesGenericsLegalNorth AmericaPatentsPharmaceuticalPozenVimovo

New biopharma firm to accelerate vaccines and protein therapeutics delivery


USA-based Caliber Biotherapeutics has announced the opening of the world's largest plant-made pharmaceutical…

Antibiotics and Infectious diseasesBiotechnologyCaliber BiotherapeuticsMarkets & MarketingNorth AmericaOncologyPharmaceuticalVaccines

AstraZeneca debuts vandetanib for medullary thyroid cancer in USA


Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that its orphan drug vandetanib is now…

AstraZenecaMarkets & MarketingNorth AmericaOncologyPharmaceuticalRare diseasesvandetanibZactima

1883 to 1898 of 1898 results

Back to top